Medicament for therapeutic treatment and/or improvement of sepsis

摘要

Disclosed is the use of thrombomodulin in the manufacture of a medicament for therapeutic treatment and/or improvement of sepsis, wherein the sepsis is severe and is accompanied with one or more organ dysfunctions, and wherein a value of International Normalized Ratio (INR) of a plasma specimen is more than 1.4. Also disclosed is the use of thrombomodulin in the manufacture of a medicament for decreasing the mortality of patients with sepsis, wherein the sepsis is severe and is accompanied with one or more organ dysfunctions, and wherein a value of International Normalized Ratio (INR) of a plasma specimen is more than 1.4.